RSS-Feed abonnieren
DOI: 10.1055/s-2004-822904
Cerium(III)-Catalyzed Cyclizations with 1-Cyanomethylene Tetrahydroisoquinoline: Substituent Controlled Formation of Fused Pyrroles or Pyridines
Publikationsverlauf
Publikationsdatum:
01. April 2004 (online)
![](https://www.thieme-connect.de/media/synlett/200406/lookinside/thumbnails/10.1055-s-2004-822904-1.jpg)
Abstract
1-Cyanomethylene-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline reacts with α,β-unsaturated aldehydes and ketones in presence of cerium(III) chloride, to yield benzo[a]quinolizines. α-Alkyl substituted unsaturated aldehydes under the same conditions, however, afford pyrrolo[2,1-a]isoquinolines.
Key words
β-enaminonitrile - cyclization - cerium(III) chloride - pyrrolo[2,1-a]isoquinolines - benzo[a]quinolizines
- 1
Erian AW. Chem. Rev. 1993, 93: 1991 - 2
O’Callaghan CN.Conlon DMA.Cardin CJ. J. Chem. Res., Synop. 1988, 288 - 3
Yamaguchi Y.Katsumaya I.Funabiki K.Matsui M.Shibata K. J. Heterocycl. Chem. 1988, 35: 805 - 4
Openshaw HT.Whittaker N. J. Chem. Soc. 1961, 4939 - 5
Nemes P.Balázs B.Tóth G.Scheiber P. Synlett 1999, 222 - 6
Nemes P.Vincze Z.Balázs B.Tóth G.Scheiber P. Synlett 2003, 250 - 7
Kobayashi S. Synlett 1994, 689 - 8
Kotsuki H.Arimura K. Tetrahedron Lett. 1997, 38: 7583 - 9
Imamoto T. Lanthanides in Organic Synthesis Academic Press; New York: 1994. - 10
Christoffers J. Eur. J. Org. Chem. 1998, 1259 - 11
Boruah A.Baruah M.Prajapati D.Sandhu JS. Synth. Commun. 1998, 28: 653 - 12
Bartoli G.Bosco M.Bellucci MC.Marcantoni E.Sambri L.Torregiani E. Eur. J. Org. Chem. 1999, 617 - 14
Christoffers J.Werner T.Unger S.Frey W. Eur. J. Org. Chem. 2003, 425
References
Preparation of Compounds 4a-e: Cerium(III) chloride heptahydrate (37 mg, 0.1 mmol) was added to stirred solution of 1 (230 mg, 1 mmol) and carbonyl compound (1 mmol) in MeCN (8 mL). The mixture was then stirred for 5-10 h at r.t. MeCN was evaporated under reduced pressure, and the residue was treated with CH2Cl2 (15 mL). The catalyst was then removed by filtration and rinsed with CH2Cl2. The combined solutions were concentrated under reduced pressure, and the crude product was purified by flash chromatography (hexane-EtOAc, 5:1).
15Preparation of Compounds 5a-c, 6a,b: Compound 1 (230 mg, 1 mmol) of was dissolved in MeCN (8 mL). Carbonyl compound (1 mmol) and cerium(III) chloride heptahydrate (37 mg, 0.1 mmol) were added, and the mixture was then stirred for 6-10 h at r.t., under simultaneous, slow passing of oxygen (ca. 60 mL/h) through the mixture. MeCN was evaporated under reduced pressure. The residue was treated under stirring with CH2Cl2 (15 mL) and the catalyst was removed by filtration and rinsed with CH2Cl2. The filtered extracts were concentrated under reduced pressure, and then the crude product was purified by flash chromatography (hexane-EtOAc, 5:1).
16NMR spectra were recorded at 300 K in CDCl3 at 500/125 MHz on a Bruker-Avance DRX-500 instrument.
4a: 1H NMR: δ = 7.84 (s, 1 H, H-11), 6.65 (s, 1 H, H-8), 4.47 (s, 1 H, H-3), 3.96 (s, 3 H, 10-MeO), 3.90 (s, 3 H, 9-MeO), 2,77 (t, 2 H, H2-7), 3.49 (t, 2 H, H2-6), 1.93 (s, 3 H, 4-Me), 1.26 (s, 6 H, 2-Me2), 13C NMR: δ = 150.0 (C-9), 147.1 (C-10), 147.0 (C-11b), 132.6 (C-4), 129.9 (C-7a), 122.6 (1-CN), 121.6 (C-11a), 111.4 (C-11), 109.8 (C-8), 109.7 (C-3), 84.1 (C-1), 56.3 (10-MeO), 56.0 (9-MeO), 42.7 (C-6), 32.0 (C-2), 31.2 (2-Me2), 29.6 (C-7), 19.4 (4-Me). 4b: 1H NMR: δ = 7.83 (s, 1 H, H-11), 6.65 (s, 1 H, H-8), 4,28 (s, 1 H, H-3), 3.96 (s, 3 H, 10-MeO), 3.90 (s, 3 H, 9-MeO), 3.46 (t, 2 H, H2-6), 2.76 (t, 2 H, H2-7), 2.24 (q, 2 H, 4-CH
2
-CH3), 1.65 (q, 2 H, 2-CH
2
-CH3), 1.27 (s, 3 H, 2-Me), 0.94 (s, 3 H, 4-CH2-CH
3
), 0.91 (s, 3 H, 2-CH2-CH
3
). 13C NMR: δ = 150.1 (C-9), 148.3 (C-11b), 147.2 (C-10) 139.4 (C-4), 130.1 (C-7a), 122.8 (1-CN), 122.1 (C-11a), 111.7 (C-11), 109.9 (C-8), 106.4 (C-3), 82.5 (C-1), 56.5 (10-MeO), 56.2 (9-MeO), 42.4 (C-6), 36.3 (C-2), 35.8 (2-CH
2
-CH3), 31.0 (2-Me), 29.9 (C-7), 25.6 (4-CH
2
-CH3
), 13.4 (4-CH2-CH
3
), 9.9 (2-CH2-CH
3
). 4c: 1H NMR: δ = 7.87 (s, 1 H, H-11), 7.40 (d, 2 H, 2-Ph), 7.38 (t, 2 H, 2-Ph), 7.37 (d, 2 H, 4-p-Cl-C6H4), 7.29 (d, 2 H, 4-p-Cl-C6H4), 7.28 (t, 1 H, 2-Ph), 6.65 (s, 1 H, H-8), 4.94 (d, 1 H, H-3), 4.44 (d, 1 H, H-2), 3.93 (s, 3 H, 10-MeO), 3.89 (s, 3 H, 9-MeO), 3.48 (t, 2 H, H2-6), 2.76 (t, 2 H, H2-7). 13C NMR: δ = 150.3 (C-9), 147.3 (C-10), 147.2 (C-11b), 145.3 (C-4), 139.7 (2-Ph), 134.6 (4-p-ClC6H4), 134.6 (4-p-Cl-C6H4), 129.7 (4-p-Cl-C6H4), 128.7 (4-p-Cl-C6H4), 129.7 (C-7a), 128.8 (2-Ph), 127.4 (2-Ph), 127.1 (2-Ph), 123.0 (1-CN), 121.2 (C-11a), 110.9 (C-11), 110.0 (C-8), 106.4 (C-3), 79.2 (C-1), 56.0 (9-MeO), 56.3 (10-MeO), 45.5 (C-6), 42.2 (C-2), 29.7 (C-7). 4d: 1H NMR: δ = 7.82 (s, 1 H, H-11), 7.36 (tm, 2 H, 2-Ph), 7.36 (dm, 2 H, 2-Ph), 7.26 (tm, 2 H, 2-Ph), 6.65 (s, 1 H, H-8), 6.08 (d, 1 H, H-4), 4.85 (dd, 1 H, H-3), 4.40 (d, 1 H, H-2), 3.89 (s, 3 H, 9-MeO), 3.89 (s, 3 H, 10-MeO), 3.51 (tm, 1 H, Hax-6), 3.42 (dm, 1 H, Heq-6), 2.92 (tm, 1 H, Hax-7), 2.76 (dm, 1 H, Heq-7). 13C NMR: δ = 150.3 (C-9), 147.3 (C-10), 146.0 (C-11b), 145.4 (2-Ph), 129.9 (C-7a), 129.7 (C-4), 128.7 (2-Ph), 127.6 (2-Ph), 127.0 (2-Ph), 123.6 (1-CN), 120.2 (C-11a), 111.1 (C-11), 110.2 (C-8), 103.6 (C-3), 76.7 (C-1), 56.2 (10-MeO), 55.9 (9-MeO), 48.7 (C-6), 42.6 (C-2), 29.5 (C-7). 4e: 1H NMR: δ = 7.77 (s, 1 H, H-11), 6.64 (s, 1 H, H-8), 3.95 (s, 3 H, 10-MeO), 3.90 (s, 3 H, 9-MeO), 3.47 (m, 2 H, H2-6), 3.21 (dd, 1 H, H-2), 2.76 (t, 2 H, H2-7), 2.55 (dt, 1 H, Heq-2d), 2.11 (dm, 1 H, Heq-2a), 1.88 (s, 3 H, 4-Me), 1.87 (dm, 1 H, Heq-2b), 1.80 (dm, 1 H, Heq-2c), 1.72 (td, 1 H, Hax-2d), 1.51 (tm, 1 H, Hax-2b), 1.49 (tm, 1 H, Hax-2a), 1.33 (tm, 1 H, Hax-2c). 13C NMR: δ = 150.0 (C-9), 147.3 (C-11b), 147.0 (C-10), 129.7 (C-7a), 125.3 (C-4), 123.8 (1-CN), 121.9 (C-11a), 113.8 (C-3), 111.2 (C-11), 109.5 (C-8), 87.4 (C-1), 56.3 (10-MeO), 55.9 (9-MeO), 43.0 (C-6), 39.6 (C-2), 35.8 (C-2a), 30.6 (C-2d), 28.0 (C-2c), 29.7 (C-7), 26.6 (C-2b), 14.3 (4-Me). 5b: 1H and 13C NMR data see Scheme
[4]
. 5a: 1H NMR: δ = 7.71 (s, 1 H, H-10), 6.71 (s, 1 H, H-7), 3.96 (s, 3 H, 9-MeO), 3.91 (s, 3 H, 8-MeO), 3.91 (t, 2 H, H2-5), 3.00 (t, 2 H, H2-6), 2.57 (q, 2 H, H2-2a), 2.17 (s, 3 H, 3-Me), 1.21 (t, 3 H, H3-2b). 13C NMR: δ = 148.6 (C-8), 148.6 (C-9), 134.4 (C-6a), 125.6 (C-2), 124.7 (C-3), 123.8 (C-10b), 120.4 (C-10a), 118.6 (1-CN), 111.1 (C-7), 106.8 (C-10), 86.4 (C-1), 56.3 (9-MeO), 56.2 (8-MeO), 41.2 (C-5), 28.6 (C-6), 18.6 (C-2a), 15.8 (C-2b), 9.6 (3-Me). 5c: 1H NMR: δ = 7.72 (s, 1 H, H-10), 6.73 (s, 1 H, H-7), 6.18 (s, 1 H, H-2), 3.96 (s, 3 H, 9-MeO), 3.93 (q, 2 H, H2-3a), 3.91 (s, 3 H, 8-MeO), 3.01 (dd, 2 H, H2-5), 2.57 (dd, 2 H, H2-6), 1.26 (t, 3 H, H3-3b). 13C NMR: δ = 148.9 (C-8), 148.7 (C-9), 135.6 (C-6a), 135.2 (C-3), 124.0 (C-10b), 120.4 (C-10a), 119.0 (1-CN), 111.1 (C-7), 108.8 (C-2), 106.9 (C-10), 85.8 (C-1), 56.2 (8-MeO), 56.1 (9-MeO), 41.1 (C-5), 28.7 (C-6), 19.5 (C-3a), 12.7 (C-3b). 6a: 1H NMR: δ = 7.69 (s, 1 H, H-10), 6.71 (s, 1 H, H-7), 3.96 (s, 3 H, 9-MeO), 3.90 (s, 3 H, 8-MeO), 3.88 (t, 2 H, H2-5), 2.98 (m, 2 H, H2-6), 2.85, 2.74 (dd + m, 1 + 1 H, H2-2a), 2.73, 1.43 (m + m, 1 + 1 H, H2-2e), 2.34 (tt, 1 H, H-2b), 2.75 (m, 1 H, H-2d), 1.42 (s, 3 H, 2c-Me), 0.69 (s, 3 H, 2c-Me). 13C NMR: δ = 148.5 (C-9), 148.1 (C-8), 138.7 (C-3), 132.9 (C-6a), 123.2 (C-10b), 120.8 (C-10a), 118.4 (1-CN), 117.1 (C-2), 111.1 (C-7), 106.3 (C-10), 85.0 (C-1), 56.1 (9-MeO), 56.0 (8-MeO), 42.1 (C-2c), 41.7 (C-2b), 40.9 (C-5), 39.4 (C-2d), 33.2 (C-2e), 28.6 (C-6), 26.4 (2c-Me), 25.9 (C-2a), 21.5 (2c-Me). 6b: 1H NMR δ = 7.68 (s, 1 H, H-10), 6.72 (s, 1 H, H-7), 3.95 (s, 3 H, 9-MeO), 3.90 (s, 3 H, 8-MeO), 3.86 (t, 2 H, H2-5), 2.98 (t, 2 H, H2-6), 2.59 (m, 2 H, H2-2a), 2.51 (m, 2 H, H2-2d), 1.85 (m, 2 H, H2-2c), 1.78 (m, 2 H, H2-2b). 13C NMR: δ = 148.7 (C-8), 148.7 (C-9), 134.4 (C-6a), 128.3 (C-3), 123.9 (C-10b), 121.6 (C-2), 120.5 (C-10a), 118.5 (1-CN), 111.3 (C-7), 106.9 (C-10), 85.4 (C-1), 56.3 (9-MeO), 56.2 (8-MeO), 40.8 (C-5), 28.6 (C-6), 23.2 (C-2b), 22.9 (C-2c), 21.8 (C-2a), 21.5 (C-2d).